MUC1 and prostate carcinoma: Our results taken together with this observation suggest that the modification of MUC1 in C2GnT-expressing prostate cancer cells with bulky poly-N-acetyllactosamine moieties reduces their adhesiveness, thereby attenuating the NK cell-cancer cell interaction.